Making Clinical Labs Green.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 32
- By:
- Publication type:
- Article
Works matching IS 01619640 AND DT 2019 AND VI 45 AND IP 2
Results: 19
1
2
BRISTOL-MYERS SQUIBB, BOSTON MEDICAL CENTER SEARCH FOR IMMUNOTHERAPY RESPONSE MARKERS.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 31
- Publication type:
- Article
3
GUARDANT HEALTH TO DEVELOP CO-DIAGNOSTICS FOR ASTRAZENECA'S CANCER DRUGS.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 31
- Publication type:
- Article
4
PERSONAL GENOME DIAGNOSTICS, PATHGROUP TO DEVELOP CANCER GENOMIC PROFILING TEST.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 31
- Publication type:
- Article
5
SOUTHEASTERN GROCERS, eTRUENORTH TO OPEN CLIAWAVED LABS IN RETAIL PHARMACIES.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 30
- Publication type:
- Article
6
JOHNSON & JOHNSON, VERACYTE PARTNER ON NONINVASIVE EARLY LUNG CANCER TESTS.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 30
- Publication type:
- Article
7
GeneCentric, UNC Unite to Improve Prediction of Bladder Cancer Drug Response.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 30
- Publication type:
- Article
8
NUGENERIX DIAGNOSTICS EARNS CE MARK FOR RAPID POC SYPHILIS TEST.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 28
- Publication type:
- Article
9
Strategies (You Will Need a Few) on How to Decide Upon and Provide Necessary STAT Testing.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 6
- By:
- Publication type:
- Article
10
Policy Would Drop Coverage for Some Cancer Testing.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 4
- Publication type:
- Article
11
FDA OKS HOLOGIC TEST FOR SEXUALLY TRANSMITTED PATHOGEN MYCOPLASMA GENITALIUM.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 28
- Publication type:
- Article
12
23ANDME GETS FDA OK FOR DTC GENETIC TEST FOR HEREDITARY COLON CANCER SYNDROME.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 28
- Publication type:
- Article
13
NEW FDA GUIDANCE AIMS TO ADVANCE DEVELOPMENT OF ANTIMICROBIAL SUSCEPTIBILITY TESTS.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 26
- Publication type:
- Article
14
FDA DRAFT GUIDANCE PROPOSES UPDATES TO DE NOVO REVIEW PATHWAY.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 26
- Publication type:
- Article
15
Miris Test for Nutrient Levels in Breast Milk Receives FDA Authorization.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 26
- Publication type:
- Article
16
MACHINE LEARNING and Laboratory Medicine NOW AND THE ROAD AHEAD: As artificial intelligence proliferates, clinical laboratorians can leverage their expertise in validating new technology to improve patient care.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 20
- By:
- Publication type:
- Article
17
A New Chapter in Women's Heart Disease: Testosterone Could Be Key Player in Higher Postmenopausal Risk.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 14
- By:
- Publication type:
- Article
18
COMPANIES FOCUS ON HELPING LABS DO MORE WITH LESS: WITH NO END IN SIGHT TO THE LAB WORKFORCE SHORTAGE, VENDORS AIM TO FILL THE GAP.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 10
- By:
- Publication type:
- Article
19
Serial Serum Neurofilament Light Chain Results Predict Cognitive Decline in Hereditary Alzheimer's Disease.
- Published in:
- Clinical Laboratory News, 2019, v. 45, n. 2, p. 8
- Publication type:
- Article